Santiago Parpal Tamburini

Company: Sprint Bioscience

Job title: Principal Scientist

Seminars:

Using Syngenic Models to Understand the Molecular Pathways Leading to Improved STING Therapy Using vps34 Inhibitors 3:00 pm

Inhibiting VPS34 enhances T-cell-recruiting chemokines through the activation of the cGAS/STING pathway Combining VPS34 inhibitors with STING agonist ADU-S100 improves tumour control in syngeneic mice models Exemplifying the use of syngeneic models in preclinical drug discovery to investigate molecular mechanisms that define the rationale for combination therapyRead more

day: Conference Day Two